OOIR: Observatory of International Research

Papers

(The TQCC of CRISPR Journal is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells	470
Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions	49
Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes	48
Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types	43
Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator	37
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient	37
Inference of CRISPR Edits from Sanger Trace Data	36
CRISPR Comparison Toolkit: Rapid Identification, Visualization, and Analysis of CRISPR Array Diversity	36
Will Advances in Genetic Medicine Lessen the Need for Germline Modifications?	36
Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes	31
Acknowledgment of Reviewers 2022	29
A Taxonomic and Phylogenetic Classification of Diverse Base Editors	29
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering	29
Curing “GFP-itis” in Bacteria with Base Editors: Development of a Genome Editing Science Program Implemented with High School Biology Students	28
Gene Editing and Rett Syndrome: Does It Make the Cut?	26
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas	26
Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection	25
Opposing Human Genetic Engineering	25
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG	23
Implementing CRISPR-Cas9 Yeast Practicals into Biology Curricula	20
Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods	20
CRISPR Crops and Sustainable Agriculture	19
Comprehensive Analysis of CRISPR-Cas9 Editing Outcomes in Yeast Xanthophyllomyces dendrorhous	19
The Roles and Responsibilities of Scientific Journals in Research Governance: Editorial Policymaking at Nature and Springer Nature (1995–2023)	17
Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing	17

Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors	17
CRISPR à la carte	16
Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 1	15
A Story of Perseverance: An Interview with Matthew Porteus	15
Widespread Impact of Natural Genetic Variations in CRISPR-Cas9 Outcomes	15
CRISPR Rewrites the Future of Medicine	15
Combined Theoretical, Bioinformatic, and Biochemical Analyses of RNA Editing by Adenine Base Editors	14
Evolution of Type IV CRISPR-Cas Systems: Insights from CRISPR Loci in Integrative Conjugative Elements of Acidithiobacillia	14
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies	14
Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements	13
Engineered Antiviral Sensor Targets Infected Mosquitoes	13
dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer	13
Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control	13
Engineering CjCas9 for Efficient Base Editing and Prime Editing	12
Institutional Bioethics: From Critical Interdisciplinarity to Cosmopolitanism	12
CRISPR Momentum in the Clinic and the Field	12
Rational Engineering of CRISPR-Cas9 Nuclease to Attenuate Position-Dependent Off-Target Effects	12
Enhancements of the CRISPR-Cas System in the Silkworm Bombyx mori	11
Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines	11
Fanzors: Mysterious TnpB-Like Bacterial Transposon-Related RNA-Guided DNA Nucleases of Eukaryotes	11
A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors	11
Spotlight on Genetic Design in a Spotted Wing Crop Killer	10
A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance	10
A PCR-Induced Mutagenesis-Restriction Fragment Length Polymorphism Method for the Detection of CRISPR-Induced Indels	10
Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative	10
It's a Knockout for Cat Allergies?	9
Warrior Spirit: An Interview with Victoria Gray, Sickle Cell Pioneer	9
Introducing Faith-Based Claims to Ethical Discourse on Scientific Matters	9
Cas12a-Capture: A Novel, Low-Cost, and Scalable Method for Targeted Sequencing	9
The CRISPR Revolution in the Drug Discovery Workflow: An Industry Perspective	9
Acknowledgment of Reviewers 2023	9
A Protein-Cutting CRISPR Complex Caught in Action	9
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13	9
Bacterial Retrons Enable Precise Gene Editing in Human Cells	9
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2	9
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects	8
Rapid Variant Pathogenicity Analysis by CRISPR Activation of CRB1 Gene Expression in Patient-Derived Fibroblasts	8
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo	8
Navigating Viral Space with CRISPR Technologies	8
Genome Editing Headwinds: Can CRISPR Stay on Target?	8
Five Years of Progress in CRISPR Clinical Trials (2019–2024)	8
The New Old Colonialism	7
Base Editing of Somatic Cells Using CRISPR–Cas9 in Drosophila	7
Correction to: APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels by Rieffer et al. The CRISPR Journal, 2023;6(5):430–446; DOI: 10.1089/crispr.2023.0027	7
Diverse Class 2 CRISPR Effectors as Active Nucleases with Expanded Targeting Capabilities	7
Reduction of Pre-Existing Adaptive Immune Responses Against SaCas9 in Humans Using Epitope Mapping and Identification	7
Special Issue: Manipulating the Microbiome with CRISPR	7
Characterization of Research Support of Genome Editing Technologies and Transition to Clinical Trials	7
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells	7
Moving Therapeutic Genome Editing into Global Clinical Trials and Medicine	7

Bio-Orthogonal Chemistry Conjugation Strategy Facilitates Investigation of N-methyladenosine and Thiouridine Guide RNA Modifications on CRISPR Activity